Transperineal ultrasound guided template biopsy does not increase the detection rate of prostate cancer in a screening populationautonomic nervesbladder, neurogenicincontinencepostural tachycardia syndrome (POTSThese studies examined the expression of the podocyte slit diaphragm protein nephrin and its association...
& Dahm, P. Screening for prostate cancer. Cochrane Database of Systematic Reviews Issue 1. Art. No.: CD004720 http://dx/doi.org/10.1002/14651858.CD004720.pub3 (2013). Emiliozzi, P. et al. Best approach for prostate cancer detection: a prospective study on transperineal versus ...
Hu and colleagues conducted a 10-center study to investigate infection risk with transperineal biopsy vs. transrectal biopsy for men with suspicion forprostate cancer. The transperineal cohort included 372 men and the transrectal group included 370 men. The transrectal group recei...
Prostate cancer is the most common condition that we treat in urologic oncology. There's over 1.5 million people each year around the world diagnosed with prostate cancer, over 200,000 people here in the United States. The mainstay in the diagnosis of prostate cancer, aside from screening, wh...
part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65:124–37. Article PubMed Google Scholar Critz FA, Benton JB, Shrake P, Merlin ML. 25-Year disease-free survival rate after irradiation for prostate cancer calculated with the prostate ...
Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology. 2002;60(5):826–30. Article PubMed Google Scholar Grummet JP, Weerakoon M, Huang S, Lawrentschuk N, Frydenberg M, Moon DA, O'...
part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65:124–37. Article PubMed Google Scholar Critz FA, Benton JB, Shrake P, Merlin ML. 25-Year disease-free survival rate after irradiation for prostate cancer calculated with the prostate ...
The European Randomized Study of Screening for Prostate (ERSPC) has updated their previous seminal report on prostate cancer mortality comparing screened men to controls. Now with 13 years follow-up, the rate ratio of prostate cancer mortality was 0.79 favoring the screened population. The authors ...
prostate cancerTo compare the accuracy of the European Randomized Study of Screening for Prostate Cancer (ERSPC) RC, MRI〦RSPC㏑C, and Prostate Biopsy Collaborative Group (PBCG) RC in patients undergoing transperineal prostate biopsy. We identified 392 patients who underwent mpMRI before ...
The presence of prostate cancer on saturation biopsy can be accurately predicted. BJU Int. 2010; 105 (5): 636–641. Google Scholar, Medline7. Heidenreich, A Bellmunt, J Bolla, M et al.; European Association of Urology. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, ...